During the past decade, Hospital de Manises conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 12 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Manises" #1 sponsor was "Cardenal Herrera University" with 5 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa" with 4 trials sponsored, "Roxall Medicina España S.A" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Manises" #1 collaborator was "Hospital de Manises" with 4 trials as a collaborator, "Universitat Politècnica de València" with 2 trials as a collaborator, "AKRN Scientific Consulting, S.L." with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Aristotle University Of Thessaloniki" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Manises" are "Psoriasis" (7 trials), "End Stage Renal Disease" (3 trials), "Rhinoconjunctivitis" (3 trials), "Asthma" (2 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "Hospital de Manises" in a lesser frequency.

Most popular intervention types in "Hospital de Manises" are "Drug" (25 trials), "Other" (9 trials), "Biological" (6 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Ruxolitinib cream" (3 trials), "Adalimumab" (2 trials), "BMS-986165" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Manises" are 50 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital de Manises". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Hospital de Manises, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Manises, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".